- Home
- PHVS vs KSS Comparison
PHVS vs KSS Comparison
Compare PHVS & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- KSS
- Stock Information
- Founded
- PHVS 2015
- KSS 1962
- Country
- PHVS Switzerland
- KSS United States
- Employees
- PHVS N/A
- KSS N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- KSS Department/Specialty Retail Stores
- Sector
- PHVS Health Care
- KSS Consumer Discretionary
- Exchange
- PHVS Nasdaq
- KSS Nasdaq
- Market Cap
- PHVS 1.3B
- KSS 1.6B
- IPO Year
- PHVS 2021
- KSS 1992
- Fundamental
- Price
- PHVS $24.30
- KSS $17.80
- Analyst Decision
- PHVS Strong Buy
- KSS Sell
- Analyst Count
- PHVS 5
- KSS 14
- Target Price
- PHVS $35.60
- KSS $11.54
- AVG Volume (30 Days)
- PHVS 123.2K
- KSS 8.8M
- Earning Date
- PHVS 11-12-2025
- KSS 08-27-2025
- Dividend Yield
- PHVS N/A
- KSS 2.90%
- EPS Growth
- PHVS N/A
- KSS N/A
- EPS
- PHVS N/A
- KSS 1.86
- Revenue
- PHVS N/A
- KSS $15,886,000,000.00
- Revenue This Year
- PHVS N/A
- KSS N/A
- Revenue Next Year
- PHVS N/A
- KSS N/A
- P/E Ratio
- PHVS N/A
- KSS $9.25
- Revenue Growth
- PHVS N/A
- KSS N/A
- 52 Week Low
- PHVS $11.51
- KSS $6.04
- 52 Week High
- PHVS $26.33
- KSS $21.39
- Technical
- Relative Strength Index (RSI)
- PHVS 59.77
- KSS 68.23
- Support Level
- PHVS $23.20
- KSS $15.02
- Resistance Level
- PHVS $24.75
- KSS $18.25
- Average True Range (ATR)
- PHVS 1.29
- KSS 0.94
- MACD
- PHVS 0.07
- KSS 0.01
- Stochastic Oscillator
- PHVS 84.81
- KSS 87.60
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About KSS Kohl's Corporation
Kohl's operates about 1,150 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also has a large digital sales operation. Women's apparel is Kohl's largest category, having generated 25% of its 2024 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.